Patient Guide: A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 32 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05963984
Status: COMPLETED
Condition: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 32 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Ocala, Florida
  • • Baltimore, Maryland
  • • Kansas City, Missouri
  • • And 29 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants - Join Clinical Trial NCTNCT05963984

How to Join This Clinical Trial - NCTNCT05963984

Learn how to participate in this PHASE2 trial studying an investigational therapy for Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer. Current status: COMPLETED.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
COMPLETED
Study Identifier
NCTNCT05963984 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 32 locations. Find a study site near you:

Clinical Research Site

Ocala, Florida 34474 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21237 - United States

Status: Contact for availability

Clinical Research Site

Kansas City, Missouri 64111 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19107 - United States

Status: Contact for availability

Clinical Research Site

Fort Worth, Texas 76104 - United States

Status: Contact for availability

Clinical Research Site

Tatabánya, Komárom-esztergom 2800 - Hungary

Status: Contact for availability

Clinical Research Site

Salgótarján, Nógrád 3100 - Hungary

Status: Contact for availability

Clinical Research Site

Budapest, 1082 - Hungary

Status: Contact for availability

Clinical Research Site

Ciudad de México, Distrito Federal 03650 - Mexico

Status: Contact for availability

Clinical Research Site

Guadalajara, Jalisco 44280 - Mexico

Status: Contact for availability

And 22 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation